Items where authors include "Peyvandi, F."

Article

Pagliari, M.T., Rosendaal, F.R., Ahmadinejad, M. et al. (29 more authors) (2022) Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study. Journal of Thrombosis and Haemostasis, 20 (5). pp. 1106-1114. ISSN 1538-7933

Miesbach, W., Chowdary, P., Coppens, M. et al. (6 more authors) (2021) Delivery of AAV‐based gene therapy through haemophilia centres—A need for re‐evaluation of infrastructure and comprehensive care: A Joint publication of EAHAD and EHC. Haemophilia, 27 (6). pp. 967-973. ISSN 1351-8216

Tosetto, A., Badiee, Z., Baghaipour, M. et al. (32 more authors) (2020) Bleeding symptoms in patients diagnosed as type 3 von willebrand disease: results from 3WINTERS‐IPS, an international and collaborative cross‐sectional study. Journal of Thrombosis and Haemostasis, 18 (9). pp. 2145-2154. ISSN 1538-7933

Peyvandi, F., Garagiola, I., Boscarino, M. et al. (3 more authors) (2019) Real‐life experience in switching to new extended half‐life products at European haemophilia centres. Haemophilia, 25 (6). pp. 946-952. ISSN 1351-8216

Menegatti, M., Palla, R., Boscarino, M. et al. (6 more authors) (2017) Minimal factor XIII activity level to prevent major spontaneous bleeds. Journal Of Thrombosis And Haemostasis, 15 (9). pp. 1728-1736. ISSN 1538-7933

Baronciani, L., Goodeve, A. and Peyvandi, F. (2017) Molecular diagnosis of von Willebrand disease. Haemophilia, 23 (2). pp. 188-197. ISSN 1351-8216

Fischer, K., Iorio, A., Lassila, R. et al. (8 more authors) (2015) Inhibitor development in non-severe haemophilia across Europe. Thrombosis and Haemostasis, 114 (4). pp. 670-675. ISSN 0340-6245

Fischer, K., Lassila, R., Peyvandi, F. et al. (8 more authors) (2015) Inhibitor development in haemophilia according to concentrate Four-year results from the European HAemophilia Safety Surveillance (EUHASS) project. THROMBOSIS AND HAEMOSTASIS, 113 (5). pp. 968-975. ISSN 0340-6245